Digestive Diseases and Sciences

, Volume 49, Issue 4, pp 565–571

Selective Granulocyte and Monocyte Adsorptive Apheresis as a First-Line Treatment for Steroid Naïve Patients with Active Ulcerative Colitis: A Prospective Uncontrolled Study

  • Yasuo Suzuki
  • Naoki Yoshimura
  • Abby R. Saniabadi
  • Yasushi Saito
Article

Abstract

Corticosteroid therapy of ulcerative colitis (UC) is associated with frequent adverse side effects and poor quality of life. Recently, adsorptive granulocyte and monocyte/macrophage apheresis has shown efficacy in patients with severe steroid refractory UC. The objective of this study was to investigate if, instead of corticosteroids, adsorptive leukocytapheresis has efficacy as the first-line therapy for steroid-naïve patients with active UC. Twenty patients, aged 15–49 years, with a mean clinical activity index (CAI) of 8.6 were recruited. Adsorptive leukocytapheresis was done with Adacolumn, which contains cellulose acetate beads as adsorptive carriers for granulocytes and monocytes (FcγR and complement receptors expressing leukocytes). Each patient received 6 to 10 leukocytapheresis sessions of 60-min duration, at 2 sessions/week. Efficacy was assessed 1 week after the last session. Post treatment, the mean CAI was 3.0 (P = 0001), and 17 of 20 patients (85%) were in remission. There were significant falls in C-reactive protein (P = 0.0003), total white cell counts (P = 0.003), neutrophils (P = 0.0029), and monocytes (P = 0.0038), an increase in lymphocytes (P = 0.001), and increases in the blood levels of soluble TNF-α receptors I (P = 0.0007) and II (P = 0.0045) in the column outflow (blood return to the patients). Further, at 8 months, 60% of patients had maintained their remission. No severe side effects were reported. In conclusion, adsorptive leukocytapheresis should reduce corticosteroid therapy in patients with moderate UC; cases with early-stage active disease may benefit most.

ulcerative colitis steroid-naïve patients clinical activity index endoscopic activity index granulocytes and monocytes/macrophages adsorptive leukocytapheresis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    McCarthy DA, Rampton DS, Liu Y-C: Peripheral blood neutrophils in inflammatory bowel disease. Morphological evidence of in vivo activation in active disease. Clin Exp Immunol 86:489-493, 1991Google Scholar
  2. 2.
    Grisham MB, Yamada T: Neutrophils, nitrogen oxides and inflammatory bowel disease, neuro-immuno-physiology of the gastrointertinal mucosa. Ann NY Acad Sci 664:103-115, 1992Google Scholar
  3. 3.
    Allison MC, Dhillon AP, Lewis WG, Pounder RE (eds): Inflammatory Bowel Disease. London, Mosby, pp 15-95, 1998Google Scholar
  4. 4.
    Tibble JA, Sigthorsson G, Bridger D, Fagerhol MK, Bjarnason I: Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119:15-22, 2000Google Scholar
  5. 5.
    Bjarnason I, Macpherson A, Menzies IS: Intestinal permeability: The basics. In Inflammatory Bowel Disease. Basic Research, Clinical Implications and Trends in Therapy. LR Sutherland, SM Collins, F Martin, RS McLeod, SR Targan, JL Wallace, CN Williams (eds). Dordrech, Kluwer Academic Press, 1994, pp 53-70Google Scholar
  6. 6.
    Bjarnason I, Macpherson A, Hollander D: Intestinal permeability: An overview. Gastroenterology 108:1566-1581, 1995Google Scholar
  7. 7.
    Cassatella MA: The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16:21-26, 1995Google Scholar
  8. 8.
    Nikolaus S, Bauditz J, Gionchetti P: Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin-10 during intestinal inflammation. Gut 42:470-476, 1998Google Scholar
  9. 9.
    Hanai H, Watanabe F, Takeuchi K, Saniabadi A, Bjarnason I: Leucocyte adsorptive apheresis for the treatment of active ulcerative colitis: A prospective uncontrolled pilot study. Clin Gastroenterol Hepatol 1:28-35, 2003Google Scholar
  10. 10.
    Brannigan AE, O'Connell PR, Hurley H: Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 13:361-366, 2000Google Scholar
  11. 11.
    Roseth AG, Schmidt PN, Fagerhol MK: Correlation between faecal excretion of Indium-111-labelled granulocytes and calprotectin, a granulocyte marker. Scand J Gastroenterol 34:50-54, 1999Google Scholar
  12. 12.
    Lee, A, Whyte M, Haslett C: Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 54:283-288, 1993Google Scholar
  13. 13.
    Meagher LC, Cousin JM, Seckl JR, Haslett C: Opposing effects of glucocorticoids on the rate of appoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 156:4422-4428, 1996Google Scholar
  14. 14.
    Truelove SC, Jewell DP: Intensive intravenous regimens for severe attacks of ulcerative colitis. Lancet 1:1067-1070, 1974Google Scholar
  15. 15.
    Jarnerot G, Rolny P, Sandberg-Gertzen H: Intensive intravenous treatment of ulcerative colitis. Gastroenterology 89:1005-1013, 1985Google Scholar
  16. 16.
    Present DH: How to do without steroids in inflammatory bowel disease. Inflamm Bowel Dis 6:48-57, 2000Google Scholar
  17. 17.
    Taffet SL, Das KM: Sulphasalazine-adverse effects and desensitization. Dig Dis Sci 28:833-842, 1983Google Scholar
  18. 18.
    Saniabadi AR, Hanai H, Takeuchi K, Bjarnason I, Lofberg R: Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 7:48-59, 2003Google Scholar
  19. 19.
    Hiraishi K, Takeda Y, Shiobara N, Shibusawa H, Jimma F, Kashiwagi N, Saniabadi AR, Adachi M: Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Ther Apher Dial 7:334-340, 2003Google Scholar
  20. 20.
    Ohara M, Saniabadi AR, Hirata I, Kasukawa R: Granulocytapheresis in the treatment of patients with rheumatoid arthritis. Artif Organs 21:989-994, 1997Google Scholar
  21. 21.
    Kashiwagi N, Hirata I, Kasukawa R: A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher 2:134-141, 1998Google Scholar
  22. 22.
    Hanai H, Watanabe F, Saniabadi A, Matsushita I, Takeuchi K, Iida T: Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Dig Dis Sci 47:2349-2353, 2002Google Scholar
  23. 23.
    Rachmilewitz D (on behalf of an international study group): Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial. Br Med J 298:82-86, 1989Google Scholar
  24. 24.
    D'Arrigo C, Candal-Couto JJ, Greer M, Veale DJ, Woof JM: Human neutrophil Fc receptor-mediated adhesion under flow: a hallow fiber model of intravascular arrest. Clin Exp Immunol 100:173-179, 1993Google Scholar
  25. 25.
    Kashiwagi N, Saniabadi A, Shimoyama T: Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 47:1334-1341, 2002Google Scholar
  26. 26.
    Tabuchi T, Saniabadi AR: Granulocyte apheresis as a possible new approach in cancer therapy: a pilot study involving two cases. Cancer Detect Prev 23:417-421, 1999Google Scholar
  27. 27.
    Biswas P, Mantelli B, Hasson H, Vecchi A, Saniabadi A, Lazzarin A, Beretta A: In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: Implications for treatment of HIV infection and other immune disorders. Clin Immunol 109:355-358, 2003Google Scholar
  28. 28.
    Mohler KM, Torrance DS, Smith GA, Widmer MB: Soluble tumour necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoximia and function simultaneously as both TNF carriers and TNF antagonists J Immunol 151:1548-1561, 1993Google Scholar
  29. 29.
    Vassalli P: The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411-452, 1992Google Scholar
  30. 30.
    Wallach D, Varfolomeer EE, Malinin NL, Goltsev YV, Boldin MP: Tumour necrosis factor receptor and fas signaling mechanisms. Annu Rev Immunol 17:331-367, 1999Google Scholar

Copyright information

© Plenum Publishing Corporation 2004

Authors and Affiliations

  • Yasuo Suzuki
    • 1
  • Naoki Yoshimura
    • 2
  • Abby R. Saniabadi
    • 3
  • Yasushi Saito
    • 2
  1. 1.Department of Internal Medicine, Sakura HospitalToho UniversitySakuraJapan
  2. 2.Clinical Cell Biology, School of MedicineChiba UniversityChiba
  3. 3.Japan Immunoresearch LaboratoriesTakasakiJapan

Personalised recommendations